Hoff, K
Compounded Semaglutide and Tirzepatide are not FDA-approved (more on that below), and a handful of states restrict which protocols are available
Jin L, Konopleva M, Shikami M, Ikegami T, Kojima K, Andreeff M , Miida T, Tabe Y
The most common gastrointestinal side effects include: Nausea : Reported in 15-44% of patients (higher rates at Wegovy 2.4 mg), typically most pronounced during dose escalation Diarrhea : Affects approximately 8-30% of users, ranging from mild to moderate severity Vomiting : Occurs in 5-24% of patients (higher rates at Wegovy 2.4 mg), often associated with rapid dose increases Abdominal pain : Experienced by 5-20% of patients, usually described as cramping or discomfort Constipation : Paradoxically affects 3-24% despite the medication's effects on motility Dyspepsia and gastroesophageal reflux : Related to delayed gastric emptying These effects result from semaglutide's pharmacologic action on GLP-1 receptors throughout the gastrointestinal tract
Originally developed to treat conditions such as high blood pressure and heart failure, spironolactone is now frequently prescribed by consultant dermatologists, like Dr Zainab Laftah, for hormonal acne and female pattern hair loss due to its anti-androgen effects
For more information about how Ozempic can affect your face, talk with your doctor
